Pavan Kumar Chintamaneni

977 total citations · 1 hit paper
26 papers, 675 citations indexed

About

Pavan Kumar Chintamaneni is a scholar working on Molecular Biology, Biomaterials and Oncology. According to data from OpenAlex, Pavan Kumar Chintamaneni has authored 26 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Biomaterials and 5 papers in Oncology. Recurrent topics in Pavan Kumar Chintamaneni's work include Nanoparticle-Based Drug Delivery (5 papers), Advanced Drug Delivery Systems (4 papers) and RNA Interference and Gene Delivery (2 papers). Pavan Kumar Chintamaneni is often cited by papers focused on Nanoparticle-Based Drug Delivery (5 papers), Advanced Drug Delivery Systems (4 papers) and RNA Interference and Gene Delivery (2 papers). Pavan Kumar Chintamaneni collaborates with scholars based in India, Ghana and Pakistan. Pavan Kumar Chintamaneni's co-authors include Sai Kiran S. S. Pindiprolu, Praveen Thaggikuppe Krishnamurthy, Akhtar Nadhman, Cláudia Viegas, Pedro Fonte, Veera Venkata Satyanarayana Reddy Karri, Shashank Tummala, Surendra Kumar, Ashish Wadhwani and B. Babu and has published in prestigious journals such as Food Chemistry, Journal of Controlled Release and RSC Advances.

In The Last Decade

Pavan Kumar Chintamaneni

25 papers receiving 662 citations

Hit Papers

Solid Lipid Nanoparticles vs. Nanostructured Lipid Carrie... 2023 2026 2024 2025 2023 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review
    2023 231 citations Cláudia Viegas, Akhtar Nadhman et al. Pharmaceutics profile →

Peers

Pavan Kumar Chintamaneni
Wujun Dong China
Lucia Ruxandra Tefas Romania
Saurav Kumar Jha India
Octavio D. Reyes‐Hernández Mexico
Riham I. El-Gogary Egypt
Sara Nikoofal‐Sahlabadi Iran
Yasamin Davatgaran Taghipour Iran
Yujun Wang China
Wensheng Zheng China
Wujun Dong China
Pavan Kumar Chintamaneni
Citations per year, relative to Pavan Kumar Chintamaneni Pavan Kumar Chintamaneni (= 1×) peers Wujun Dong

Countries citing papers authored by Pavan Kumar Chintamaneni

Since Specialization
Citations

This map shows the geographic impact of Pavan Kumar Chintamaneni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavan Kumar Chintamaneni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavan Kumar Chintamaneni more than expected).

Fields of papers citing papers by Pavan Kumar Chintamaneni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pavan Kumar Chintamaneni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavan Kumar Chintamaneni. The network helps show where Pavan Kumar Chintamaneni may publish in the future.

Co-authorship network of co-authors of Pavan Kumar Chintamaneni

This figure shows the co-authorship network connecting the top 25 collaborators of Pavan Kumar Chintamaneni. A scholar is included among the top collaborators of Pavan Kumar Chintamaneni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavan Kumar Chintamaneni. Pavan Kumar Chintamaneni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chintamaneni, Pavan Kumar, Sai Kiran S. S. Pindiprolu, Veera Venkata Satyanarayana Reddy Karri, et al.. (2024). Conquering chemoresistance in pancreatic cancer: Exploring novel drug therapies and delivery approaches amidst desmoplasia and hypoxia. Cancer Letters. 588. 216782–216782. 19 indexed citations
2.
Chintamaneni, Pavan Kumar, Rashmi Saxena Pal, MVNL Chaitanya, et al.. (2023). From nature's bounty to drug discovery: Leveraging phytochemicals and molecular approaches to combat multi-drug-resistant (MDR) tuberculosis. Indian Journal of Tuberculosis. 71. S117–S129. 2 indexed citations
3.
Viegas, Cláudia, et al.. (2023). Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review. Pharmaceutics. 15(6). 1593–1593. 231 indexed citations breakdown →
4.
Chintamaneni, Pavan Kumar, et al.. (2022). Engineered upconversion nanocarriers for synergistic breast cancer imaging and therapy: Current state of art. Journal of Controlled Release. 352. 652–672. 20 indexed citations
5.
Pindiprolu, Sai Kiran S. S., et al.. (2020). DR5 antibody conjugated lipid-based nanocarriers of gamma-secretase inhibitor for the treatment of triple negative breast cancer. Chemistry and Physics of Lipids. 235. 105033–105033. 25 indexed citations
6.
Pindiprolu, Sai Kiran S. S., et al.. (2020). Phenyl Boronic Acid-Modified Lipid Nanocarriers of Niclosamide for Targeting Triple-Negative Breast Cancer. Nanomedicine. 15(16). 1551–1565. 28 indexed citations
7.
Krishnamurthy, Praveen Thaggikuppe, et al.. (2020). Novel drug delivery systems of β2 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson’s disease management. Expert Opinion on Drug Delivery. 17(8). 1119–1132. 13 indexed citations
8.
Krishnamurthy, Praveen Thaggikuppe, et al.. (2019). Type-II endometrial cancer: role of adipokines. Archives of Gynecology and Obstetrics. 300(2). 239–249. 20 indexed citations
9.
Narenderan, S. T., S. N. Meyyanathan, Veera Venkata Satyanarayana Reddy Karri, B. Babu, & Pavan Kumar Chintamaneni. (2019). Multivariate response surface methodology assisted modified QuEChERS extraction method for the evaluation of organophosphate pesticides in fruits and vegetables cultivated in Nilgiris, South India. Food Chemistry. 300. 125188–125188. 34 indexed citations
10.
Krishnamurthy, Praveen Thaggikuppe, et al.. (2019). Possible role of Thiazolidinedione in the management of Type-II Endometrial Cancer. Medical Hypotheses. 126. 78–81. 2 indexed citations
11.
Krishnamurthy, Praveen Thaggikuppe, et al.. (2019). Possible role of PPAR-γ and COX-2 receptor modulators in the treatment of Non-Small Cell lung carcinoma. Medical Hypotheses. 124. 98–100. 18 indexed citations
12.
Chintamaneni, Pavan Kumar, et al.. (2018). Cytosolic lipid excess-induced mitochondrial dysfunction is the cause or effect of high fat diet-induced skeletal muscle insulin resistance: a molecular insight. Molecular Biology Reports. 46(1). 957–963. 32 indexed citations
13.
Pindiprolu, Sai Kiran S. S., Praveen Thaggikuppe Krishnamurthy, & Pavan Kumar Chintamaneni. (2018). Pharmacological targets of breast cancer stem cells: a review. Naunyn-Schmiedeberg s Archives of Pharmacology. 391(5). 463–479. 19 indexed citations
14.
Wadhwani, Ashish, Ramesh C. Gupta, Pavan Kumar Chintamaneni, et al.. (2018). An effective treatment approach of DPP-IV inhibitor encapsulated polymeric nanoparticles conjugated with anti-CD-4 mAb for type 1 diabetes. Drug Development and Industrial Pharmacy. 44(7). 1120–1129. 8 indexed citations
15.
Pindiprolu, Sai Kiran S. S., et al.. (2018). Formulation-optimization of solid lipid nanocarrier system of STAT3 inhibitor to improve its activity in triple negative breast cancer cells. Drug Development and Industrial Pharmacy. 45(2). 304–313. 41 indexed citations
16.
17.
Basavan, Duraiswamy, et al.. (2017). Possible Targets of Herbals for Type 3 Diabetes: A Review. Current Traditional Medicine. 2(3). 148–185. 2 indexed citations
18.
Pindiprolu, Sai Kiran S. S., et al.. (2017). RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: in vitro studies. Artificial Cells Nanomedicine and Biotechnology. 46(2). 387–397. 49 indexed citations
19.
Chintamaneni, Pavan Kumar, et al.. (2017). Optimization of paclitaxel loaded poly (ε-caprolactone) nanoparticles using Box Behnken design. Beni-Suef University Journal of Basic and Applied Sciences. 6(4). 362–373. 40 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wujun Dong Breakdown of academic impact, for papers by Lucia Ruxandra Tefas Breakdown of academic impact, for papers by Saurav Kumar Jha Breakdown of academic impact, for papers by Octavio D. Reyes‐Hernández Breakdown of academic impact, for papers by Riham I. El-Gogary Breakdown of academic impact, for papers by Sara Nikoofal‐Sahlabadi Breakdown of academic impact, for papers by Yasamin Davatgaran Taghipour Breakdown of academic impact, for papers by Yujun Wang Breakdown of academic impact, for papers by Wensheng Zheng
Rankless by CCL
2026